Cargando…
Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of contr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493883/ https://www.ncbi.nlm.nih.gov/pubmed/32555364 http://dx.doi.org/10.1038/s41416-020-0919-2 |
_version_ | 1783582647109287936 |
---|---|
author | Baumann, Brian C. Hallahan, Dennis E. Michalski, Jeff M. Perez, Carlos A. Metz, James M. |
author_facet | Baumann, Brian C. Hallahan, Dennis E. Michalski, Jeff M. Perez, Carlos A. Metz, James M. |
author_sort | Baumann, Brian C. |
collection | PubMed |
description | Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of controversy and data are relatively limited. We comment on recently published studies and discuss future directions for proton therapy. |
format | Online Article Text |
id | pubmed-7493883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74938832021-06-18 Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy Baumann, Brian C. Hallahan, Dennis E. Michalski, Jeff M. Perez, Carlos A. Metz, James M. Br J Cancer Comment Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of controversy and data are relatively limited. We comment on recently published studies and discuss future directions for proton therapy. Nature Publishing Group UK 2020-06-18 2020-09-15 /pmc/articles/PMC7493883/ /pubmed/32555364 http://dx.doi.org/10.1038/s41416-020-0919-2 Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
spellingShingle | Comment Baumann, Brian C. Hallahan, Dennis E. Michalski, Jeff M. Perez, Carlos A. Metz, James M. Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
title | Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
title_full | Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
title_fullStr | Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
title_full_unstemmed | Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
title_short | Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
title_sort | concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493883/ https://www.ncbi.nlm.nih.gov/pubmed/32555364 http://dx.doi.org/10.1038/s41416-020-0919-2 |
work_keys_str_mv | AT baumannbrianc concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy AT hallahandennise concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy AT michalskijeffm concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy AT perezcarlosa concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy AT metzjamesm concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy |